Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation

American Journal of Kidney Diseases

Volumn 28, Issue 4, 1996, Pages 561-571

  Young, Bessie A ^a   Marsh, Christopher L ^c   Alpers, Charles E ^c   Davis, Connie L ^b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c NONE

Author keywords

aspirin; calcium channel blocker; Cyclosporine; FK506; hemolytic uremic syndrome; isradipine; kidney pancreas transplantation; pentoxifylline; renal transplantation; thrombotic microangiopathy; thrombotic thrombocytopenic purpura

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; ISRADIPINE; PENTOXIFYLLINE; TACROLIMUS;

ADULT; AGED; ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG INDUCED DISEASE; FEMALE; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PANCREAS TRANSPLANTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0029818818     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90468-0     Document Type: Article

References (62)

1. Ruggenenti P, Remuzzi G: Thrombotic microangiopathies. Crit Rev Oncol Hematol 11:243-265, 1991
2. Abramowicz D, Pradier O, Marchant A, Florquin S, De Pauw L, Vereerstaeten P, Kinnaert P, Vanherwefhem JL, Goldman M: Induction of thrombosis within renal grafts by high-dose prophylactic OKT3. Lancet 339:777-778, 1993
3. Schlumpf R, Candinas D, Weder W, Rothlin M, Zollinger A, Bleisch J, Retsch M, Largiader F: Acute vascular rejection with hemolytic uremic syndrome in kidneys from non-heart-beating donors: Association with secondary grafts and early cyclosporine treatment. Transplant Proc 25:1518-1521, 1993
4. Schlanger RE, Henry ML, Sommer BG, Ferguson RM: Identification and treatment of cyclosporine-associated allograft thrombosis. Surgery 100:329-333, 1986
5. McCauley J, Bronsther O, Fung J, Todo S, Starzl TE: Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet 2:1516, 1989
6. McCauley J, Shapiro R, Bronster O, Jordan M, Ellis D, Giboa N, Scantlebury V, Jensen C, Jain A, Starzl T: Renal transplantation under FK506 in patients with previous loss of renal function due to hemolytic uremic syndrome. Transplant Proc 23:3068-3070, 1991
7. Demetris AJ, Banner B, Fung J, Shapiro R, Jordan M, Starzl TE: Histopathology of human renal allograft rejection under FK 506: A comparison with cyclosporine. Transplant Proc 23:944-946, 1991
8. Ichihashi T, Naie T, Yoshida H, Kiyoi H, Fukutani H, Kubo K, Yamauchi T, Saito H, Ohno R: Haemolytic uraemic syndrome during FK506 therapy. Lancet 340:60-61, 1992
9. Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ: The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Am J Surg Pathol 17:60-68, 1993
10. Verpooten GA, Paulus GJ, Roels F, De Broe ME: De novo occurrence of hemolytic-uremic syndrome in a cyclosporine-treated renal allograft patient. Transplant Proc 2:2943-2945, 1987
11. Venkat KK, Tkach D, Kupin W, Mozea M, Oh HK, Raman BKS, Visscher D, Lee MW: Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant patients. Transplant Proc 23:1256-1257, 1991
12. Hochstetler LA, Flanigan MJ, Lager DJ: Transplant-associated thrombotic microangiopathy: The role of IgG administration as initial therapy. Am J Kidney Dis 23:444-450, 1994
13. Bolin P, Jennette JC, Mandel SR: Cyclosporine-associated thrombotic microangiopathy: Successful retreatment with cyclosporine. Ren Fail 13:275-278, 1991
14. Epstein M, Landsberg D: Cyclosporine-induced thrombotic microangiopathy resulting in renal allograft loss and its successful reuse: A report of two cases. Am J Kidney Dis 17:346-348, 1991
15. Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay HEM, Lawson D, McElwain TJ, Alexander P: Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet 1:327-329, 1980
16. Shulman H, Striker G, Deeg HJ, Kennedy M, Storb R, Thomas ED: Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N Engl J Med 305:1392-1395, 1981
17. Remuzzi G, Bertani T: Renal vascular and thrombotic effects of cyclosporine. Am J Kidney Dis 13:261-272, 1989
18. Leithner C, Sinzinger H, Pohanka E, Schwarz M, Kretschmer G, Syre G: Occurrence of hemolytic uremic syndrome under cyclosporine treatment: Accident or possible side effect mediated by a lack of prostacyclin-stimulating plasma factor? Transplant Proc 4:2787-2789, 1983
19. Sommer BG, Innes JT, Whitehurst RM, Sharma HM, Ferguson RM: Cyclosporine-associated renal arteriopathy resulting in loss of allograft function. Am J Surg 149:756-764, 1985
20. Neild GH, Ivory K, Williams DG: Glomerular thrombosis and cortical infarction in cyclosporine-treated rabbits with acute serum sickness. Br J Exp Pathol 65:133-144, 1983
21. Hughes DA, Beattie TJ, Murphy AV: Haemolytic uraemic syndrome: 17 Years' experience in a Scottish paediatric renal unit. Scott Med J 36:12-15, 1991
22. Robson WLM, Leung AKC, Montgomery MD: Causes of death in hemolytic uremic syndrome. Child Nephrol Urol 11:228-233, 1991
23. Herbish AS, Rasheed SA: Persistent insulin-dependent diabetes mellitus in hemolytic uremic syndrome. Child Nephrol Urol 12:59-61, 1992
24. Oursler DP, Holly KE, Wagoner RD: Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation. Am J Nephrol 13:167-170, 1993
25. Noël C, Sauneir P, Hazzan M, Pruvot F, Dracon M, Jude B, Lelievre G: Incidence and clinical profile of microvascular complications in renal allograft patients treated with cyclosporine. Ann Med Interne (Paris) 143:33-36, 1992
26. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G: Cyclosporin-induced endothelial cell injury. Lab Invest 55:455-461, 1986
27. Bunchman TE, Brookshire CA: Cyclosporine stimulated synthesis of endothelin by human endothelial cells in tissue culture. J Clin Invest 88:310-314, 1991
28. Collins P, Jones B, Uthayakumar S, Pocock C, Jupp R, Gutteridge C, Chopra R, Blare S, Newland A: Hemostatic changes in uncomplicated bone marrow transplants. Bone Marrow Transplant 7:54, 1991 (suppl 2)
29. Coomber BL: Influence of mitomycin C on endothelial monolayer regeneration in vitro. J Cell Biochem 50:293-300, 1992
30. Thompson CE, Damon LE, Reis CA, Linker CA: Thrombotic microangiopathies in the 1980's: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 8:1890-1895, 1992
31. Butthep P, Bunyaratvej A: Dengue virus and endothelial cell: A related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 24:246-249, 1993 (suppl 1)
32. Lian EC-Y, Harkness DR, Byrnes JJ, Wallach H, Nunez R: The presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura and its inhibition by normal plasma. Blood 53:333-338, 1979
33. Marcus AJ: Thrombosis and inflammation as multicellular processes: Significance of cell-cell interactions. Semin Hematol 31:261-269, 1994
34. Textor SC, Burnett JC, Romero JC, Canzanello VJ, Taler SJ, Wiesner R, Porayko M, Krom R, Gores G, Hay E: Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int 47:1426-1433, 1995
35. Tonshoff B, Schweer H, Momper R, Scharer K, Kuhl PG, Seyberth HW: Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney Int 37:1134-1141, 1990
36. Pradier O, Marchant A, Abramowicz D, De Pauw L, Vereerstraeten P, Kinnaert P, Vanherweghem JL, Goldman M: Procoagulant effect of the OKT3 monoclonal antibody: Involvement of tumor necrosis factor. Kidney Int 42:1124-1129, 1992
37. Suthanthiran M, Haschemeyer RH, Riggio RR, Adubor C, Friedman GS, Cheigh JS, Wang JC, Fotino M, Stubenbord WT, Saal SD, Stenzel KH, Rubin AL: Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. Transplantation 55:1008-1013, 1993
38. Palmer BF, Dawidson I, Sagalowsky A, Sandor Z, Lu CY: Improved outcome of cadaveric renal transplantation due to calcium channel blockers. Transplantation 52:640-645, 1991
39. Gecim IE, Christmas SE, Brew R, King A, McDicken I, Sells RA, Bakran A: The relationship between calcium antagonist therapy and growth of T lymphocytes form human renal allograft biopsies. Transplantation 56:1015-1016, 1993
40. Jennings WC, Smith J, Corry RJ: Thrombosis in human pancreatic transplantation associated with elevated cyclosporine levels and possible protection by antihypertensive agents. J Okla State Med Assoc 83:255-257, 1990
41. Epstein M, Loutzenhiser RD: Renal hemodynamic effects of calcium antagonists: Implications for renal transplantation. Transplant Proc 23:1775-1777, 1991
42. Rooth P, Dawidson I, Clothier N, Diller K: In vivo fluorescence microscopy of kidney subcapsular blood flow in mice. Transplantation 46:566-569, 1988
43. Dawidson I, Rooth P, Fry WR, Sandor Z, Williams C, Coorpender L, Alwau C, Reisch J: Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation 48:575-580, 1989
44. Endresen L, Pran T, Bergan S, Sinding-Larsen B, Holdaas H, Berg KJ: Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients. Ther Drug Monit 13:490-495, 1991
45. Berg KJ, Hartmann A, Holdaas H, Pran T, Endresen L, Solbu D, Fauchald P: Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients. Nephrol Dial Transplant 6:725-730, 1991
46. Wilt TJ: Current strategies in the diagnosis and management of lower extremity peripheral vascular disease. J Gen Intern Med 7:87-101, 1992
47. Carrier M, Perrault LP, Tronc F, Stewart DJ, Pelletier CL: Pentoxifylline decreases cyclosporine-induced renal endothelin release and vasoconstriction. Ann Thorac Surg 55:490-492, 1993
48. Zabel P, Schlaak M, Schade FU: Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187:447-463, 1993
49. Alegre ML, De Pauw L, Gastaldello K, Vandenabeele P, Abramowicz D, Moser M, Kinnaert P, Leo O, Vereerstraeten P, Goldman M: Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome. Transplantation 52:674-679, 1991
50. Canpolat C, Jaffe N, Pearson P: Cisplatin-associated hemolytic uremic syndrome. Cancer 74:3059-3062, 1994
51. Doll DC, Ringenberg QS, Yarbro JW: Vascular toxicity associated with antineoplastic agents. J Clin Oncol 4:1405-1417, 1986
52. Chappell ME, Keeling DM, Prentice HG, Sweny P: Haemolytic uraemic syndrome after bone marrow transplantation: An adverse effect of total body irradiation? Transplantation 3:339-347, 1988
53. Copeland JR, Moore SF, Willoughby KA, Ellis EF, Tynan TM: Endothelial and nonendothelial cyclooxygenase mediates rabbit pial arteriole dilation by bradykinin. Am J Physiol 268:H458-466, 1995
54. Shanberge JN, Quattrociocchi-Longe T, Kajiwara Y: Effect of aspirin and iloprost on adhesion of platelets to intact endothelium in vivo. J Lab Clin Med 125:96-101, 1995
55. Schilling M, Saunder A, Ametani M, Southard JH, Belzer FO: Prolonged kidney preservation by inhibition of arachidonic acid metabolism. Transplant Proc 25:1629-1630, 1993
56. Saunder A, Southard JH, Belzer FO: Beneficial effect of aspirin and heparin in three-day dog kidney preservation. Transplantation 56:1044-1045, 1993
57. Imperiale TF, Petrulis AS: A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 266:260-265, 1991
58. Katznelson S, Wilkinson W, Rosenthal TR, Cohen A, Nast C, Danovitch GM: Cyclosporine-induced hemolytic uremic syndrome: Factors that obscure its diagnosis. Transplant Proc 26:2608-2609, 1994
59. Bonsib SM, Ercolani L, Ngheim D, Hamilton HE: Recurrent thrombotic microangiopathy in a renal allograft. Am J Med 79:520-527, 1985
60. Lucca LJ, Ressurreicao FAMS, Ferraz AS, Costa RS, Cost JAC, Piso TM, Alves MR: De novo hemolytic uremia syndrome: A rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine. Transplant Proc 24:3098-3099, 1992
61. Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, DeMarco T: Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient. J Heart Lung Transplant 12:440-444, 1993
62. Pahl MV: Renal dysfunction and microangiopathic changes in a renal transplant patient. Am J Nephrol 8:72-79, 1988